Montag & Associates’s National Vision EYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-180,000
Closed -$2.3M 972
2025
Q1
$2.3M Hold
180,000
0.12% 151
2024
Q4
$1.88M Hold
180,000
0.09% 183
2024
Q3
$1.96M Sell
180,000
-5,000
-3% -$58.3K 0.09% 183
2024
Q2
$2.42M Hold
185,000
0.12% 148
2024
Q1
$4.1M Hold
185,000
0.2% 110
2023
Q4
$3.87M Hold
185,000
0.22% 100
2023
Q3
$2.99M Hold
185,000
0.19% 121
2023
Q2
$4.49M Hold
185,000
0.28% 86
2023
Q1
$3.49M Sell
185,000
-15
-0% -$488 0.23% 100
2022
Q4
$7.17M Buy
185,015
+15
+0% +$562 0.48% 59
2022
Q3
$6.04M Hold
185,000
0.42% 63
2022
Q2
$5.09M Buy
185,000
+180,000
+3,600% +$5.93M 0.33% 79
2022
Q1
$218K Hold
5,000
0.01% 380
2021
Q4
$240K Buy
+5,000
New +$268K 0.01% 371

Other funds holding EYE

Montag & Associates's EYE Position: Q2 2025 in Review

Montag & Associates sold out of National Vision (EYE) in Q2 2025, closing a stake of 180,000 shares — an estimated $2.3M sold.

Montag & Associates first reported a position in EYE in Q4 2021 and held it in 14 quarters. The position peaked at $7.17M in Q4 2022. 245 funds tracked by Wall St. Rank hold EYE as of Q2 2025.

  • Montag & Associates reported no remaining National Vision position as of Q2 2025 after selling out during the quarter.
  • Montag & Associates sold 180,000 National Vision shares in Q2 2025, an estimated $2.3M.
  • Montag & Associates first reported a position in National Vision in Q4 2021 and held it in 14 quarters.
  • Montag & Associates's National Vision position peaked at $7.17M in Q4 2022.
  • 245 funds tracked by Wall St. Rank held National Vision as of Q2 2025.

Based on Montag & Associates's 13F filing for Q2 2025, filed 7 Aug 2025.